Acorn Bioventures, L.P. - May 15, 2025 SCHEDULE 13D/A Report for OnKure Therapeutics, Inc. Common stock, par value $0.0001 per share (OKUR)

Filing Manager: Acorn Bioventures, L.P.
Reporting Manager: Anders Hove
Security: OnKure Therapeutics, Inc. Common stock, par value $0.0001 per share
Symbol: OKUR
Shares outstanding: 12.8M shares
Disclosed Ownership: 2.84M shares
Ownership: 22.1%
Form type: SCHEDULE 13D/A
Date filed: 5/30/2025, 03:57 PM
Date of event: May 15, 2025
SEC: View on sec.gov

Reporting Managers (5)

Name	Ownership	Shares Owned	sole voting power	Signature	Title	CIK
ACORN BIOVENTURES, L.P.	13.3%	1.71M	1.71M	Anders Hove	Manager of General Partner	0001766853
ACORN CAPITAL ADVISORS GP, LLC	13.3%	1.71M	1.71M	Anders Hove	Manager	0001813692
Anders Hove	22.1%	2.84M	2.84M	Anders Hove	Individually
ACORN BIOVENTURES 2, L.P.	8.8%	1.13M	1.13M	Anders Hove	Manager of General Partner	0001876405
Acorn Capital Advisors GP 2, LLC	8.8%	1.13M	1.13M	Anders Hove	Manager